VICTREX PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,269 GBX | -0.08% |
|
-1.71% | -16.69% |
| 10:28am | Peel Hunt starts NatWest and Barclays at 'buy' | AN |
| Mar. 15 | Victrex plc Appoints Urmi Prasad Richardson as Non-Executive Director, Effective from May 1, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Victrex plc is a United Kingdom-based holding company. The principal activity of the Company is the manufacture and sale of high-performance polymers. The Company develops solutions in polyetheretherketone (PEEK) and polyaryletherketone (PAEK) based polymers and selects semi-finished and finished parts. The Company operates through two segments: Sustainable Solutions and Medical. The Sustainable Solutions segment focuses on its energy and industrial, value-added resellers (VAR), automotive, aerospace and electronics markets. The Medical segment is focused on providing specialist solutions for medical device manufacturers. The Companyâs subsidiaries include Victrex Manufacturing Limited, Invibio Limited, Invibio Knees Limited, Invibio Device Component Manufacturing Limited and Juvora Limited.
Sector
Specialty Chemicals
Calendar
2024-05-12
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
12.7
GBP
Average target price
15.2
GBP
Spread / Average Target
+19.67%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -16.69% | 1.38B | |
| +10.52% | 62.67B | |
| -6.28% | 45.97B | |
| +12.17% | 39.51B | |
| +17.90% | 26.04B | |
| +0.51% | 17.71B | |
| +5.18% | 15.44B | |
| -27.99% | 14.54B | |
| -22.62% | 13.14B | |
| -23.93% | 13.09B |
- Stock Market
- Equities
- VCT Stock
- News Victrex plc
- Barclays Raises Victrex to Overweight from Equalweight, Lifts PT
